Mast Therapeutics, Inc. (MSTX)

[biopharm]

I simply don't agree... what happened to all the seasoned expert analysts proclaiming that 10 - 30x earnings as fair value. Now take 100-200 Million in projected earnings and the low end of 100 million... with low end of 10x earnings = 1 Billion at the very very very least bottom end and now taking the very very very bottom end of this and we sit at the $16 pps as previously projected.

This cracks me up.... now since ANX is right around the corner from their FDA decision .... now some friends of friends of friends want to come out and say we're overvalued LOL

Where were they when ANX was much much higher before the 1:5 reverse split they didn't think that was too high? lol

Shorts are about to be squeezed big time in August